Form D · Other Health Care

Salus Scientific Corp.

Charleston, SC · CIK 0001952070

Offering snapshot reported Oct 22, 2026 · SEC filing

Reported sold
Yet to sell
Offering amount: $30M
Investors reported
0
Form D · investor count
Minimum accepted
$250K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 22, 2026InitialYet to sellNo comparison0SEC filing
Aug 5, 2026Amendment$10,120,000$9,981,500vs Feb 9, 20261SEC filing
Feb 9, 2026Initial$138,500No comparison1SEC filing
Oct 29, 2024InitialYet to sellNo comparison0SEC filing
Nov 10, 2022Initial$335,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$1.3M (estimated)
Finders' fees
$0
Form D file number
021-602167

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Jeffrey S. Goodman002607530Ankura Capital Advisors, LLC · CRD 000114155

Source: Form D, filed Oct 22, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
William Buchanan Director
Todd Flohr Director, Executive
Ryan Majoria Director
C. William Martin Director
Richard Moore Director
Keith Rosmarin Executive
Ryan Sancho Director
Ronald Sancho Director
Jon Wallace Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
229 Huger St. 3 Rd Floor
Charleston, SC, 29403